Sleep Apnea Implants Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product Type, by Indication, by End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

Sleep Apnea Implants Market Research, 2031

The global sleep apnea implants market was valued at $314.3 million in 2021, and is projected to reach $1.3 billion by 2031, growing at a CAGR of 15.4% from 2022 to 2031. Sleep apnea is a common condition in which the breathing stops and restarts many times while in sleep. This can prevent the body from getting enough oxygen. There are two types of sleep apnea namely, obstructive sleep apnea and central sleep apnea. Obstructive sleep apnea happens when the upper airway becomes blocked many times while in sleep, reducing or completely stopping airflow. Central sleep apnea happens when the brain does not send the signals needed to breathe. The health conditions that affect how the brain controls the airway and chest muscles can cause central sleep apnea. These conditions can be well treated with the help of sleep apnea implant device. A sleep apnea implant is a device that helps to breathe during sleep.

Historical overview 

The market was analyzed qualitatively and quantitatively from 2021-2031. The sleep apnea implants market grew at a CAGR of around 15.9% during 2022-2031. Most of the growth during this period was derived from the North America owing to the improving health awareness, rising disposable incomes, as well as well-established presence of domestic companies in the region.    

Market dynamics 

Growth & innovations in the medical device industry for the manufacturing of sleep apnea implants owing to massive pool of sleep apnea incidences that creates an Sleep Apnea Implants Market Opportunity. Rise in launch of implant devices made up of advanced technology by various key players across the globe is set to affect the market growth positively. For instance, in May 2019, Siesta Medical announced that U.S. Food and Drug Administration (FDA) has approved its Encore System for extended indications. The Encore System was employed in AIRLIFT hyoid suspension that is used to treat airway obstructions and obstructive sleep apnea severity. This development helped the company to drive its revenue generation thereby improving the growth. The growth of the Sleep Apnea Implants Market Size is also expected to be driven by high potential in untapped, emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of sleep apnea, and surge in demand for sleep apnea implants. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare and surgical services, significant investments by government to improve healthcare infrastructure, and development of the medical technology industry in emerging countries. E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods during the pandemic. This is attributed to further supports market growth. The demand for sleep apnea implants is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the Sleep Apnea Implants Market Size. Factors such as rise in adoption of respiratory testing kits, and increase in awareness towards sleep apnea, further drive the growth of the market. Furthermore, rise in consumer awareness related to treatment procedures for sleep apnea and ease of accessibility of the implant procedures boost the adoption of sleep apnea implants. Moreover, increase in promotional activities by manufacturers and various strategies that maybe be adopted by the market player for the expansion of the business are expected to fuel the growth of the sleep apnea implants market in the near future.  

Though the use of treatment options like sleep apnea implant devices has propelled a changeover trend among the patients from using continuous positive airway pressure (CPAP) devices to sleep implant devices, there is still a long way for this paradigm shift to take total effect as the device and procedure cost concerns for the implantation is creating an enormous downfall in the Sleep Apnea Implants Market Growth. For instance, in 2019, the Inspire Medical System’s hypoglossal nerve stimulation implant was priced at $23,800 in the U.S. & $23,400 in Europe. All it lead to is one major drawback for patients that they were unable to afford it and that affected in the decrease in the demand of the devices among the populations and also among the healthcare providers. Moreover, the unfavorable regulatory scenarios of the products used for testing is also anticipated to hamper the growth of the market. 

The COVID-19 pandemic affected the sleep apnea implants industry in a negative way, like various other medical device industries were affected. The COVID-19 has affected the medical device companies by hampering supply chain. The pandemic slowed down the growth of the sleep apnea implants market amidst the initial phase of the COVID-19 pandemic, in the first half of 2020. Moreover, to control the spread of the SARS-CoV-2 virus, the national emergencies and lockdowns were enforced in several countries. It is due to the increase in cases of COVID-19 each day globally. Moreover, The pandemic has significantly affected surgical procedures resulting in a decrease in surgical procedures and implantations across the world. For instance, according the article published by the NHS England in August 2022, there were more than 22,500 people who had been waiting two years or more at the start of the year, and a further 51,000 who would have breached two years by the end of July to have also been treated. In addition, the market growth was also affected by various transport restrictions imposed globally to curb the spread of the pandemic.

Segmental Overview 

The global sleep apnea implants market is segmented based on product type, indication, end user and region. On the basis of product type, the market is classified into hypoglossal neurostimulation devices, phrenic nerve stimulator and others. On the basis of indication, the market is classified into obstructive sleep apnea and central sleep apnea. On the basis of end user, the market is classified into hospitals, ambulatory surgical center and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

The hypoglossal neurostimulation devices segment dominated the global market in 2021, and is expected to remain dominant throughout the Sleep Apnea Implants Market Forecast period, owing to increase in adoption of hypoglossal neurostimulation devices for treatment procedures of sleep apnea and availability of numbers of sleep apnea implants in the market by various key players.  

The obstructive sleep apnea segment dominated the global market in 2021, and is anticipated to continue this trend during the forecast period. This is attributed to increase in application of sleep apnea implants in treatment of sleep apnea. In addition, high number of sleeping disorders patients, surge in overweight and obese population with increase in the demand fоr pathological diagnostics are expected to propel the growth of the market. 

The hospitals segment held the largest Sleep Apnea Implants Market Share in 2021, and is expected to remain dominant throughout the forecast period, owing to increase in the number of implant surgeries performed in the hospitals for better management of the sleep apnea, and increase in the number of patients visits for the surgeries that increase the demand of the implant devices thereby driving the market growth.

In 2021, North America was the dominant region and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of sleep apnea, increase in the number market players in  and surge in the treatment procedures performed in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of sleep disorders, and the increasing number of strategies and trends adopted by the market players.

COMPETITION ANALYSIS 

Competitive analysis and profiles of the major players in the sleep apnea implants, such as Asahi Kasei Corporation, Avery biomedical, Inspire Medical Systems, Inc., LinguaFlex, Inc., LivaNova PLC, Medtronic plc, Nyxoah SA, Siesta Medical, SomnoMed, Somnowell are provided in this report. There are some important players in the market such as Asahi Kasei Corporation, Inspire Medical Systems, Inc., Medtronic plc and Nyxoah SA. Major players have adopted product approval and acquisition as key developmental strategies to improve the product portfolio of the sleep apnea implants market.   

Some examples of product approval in the market 

In March 2019, Nyxoah SA announced the European CE mark approval for the Genio System for the treatment of obstructive sleep apnea. 

In August 2020, Inspire Medical Systems, Inc. announced that the Australian Therapeutic Goods Administration approved inspire system therapy to treat obstructive sleep apnea. 

In August 2021, Zoll Medical Corporation, an Asahi Kasei Company, announced that it has received U.S. Food and Drug Administration (FDA) approval for the remedy EL-X System for the treatment of central sleep apnea.  

Acquisitions in the market  

In February 2021, Zoll Medical Corporation, a subsidiary of Asahi Kasai Corporation has announced the acquisition of Respicardia, Inc., a medical device company that manufactures sleep apnea devices. 

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the sleep apnea implants market analysis from 2021 to 2031 to identify the prevailing sleep apnea implants market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the sleep apnea implants market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global sleep apnea implants market trends, key players, market segments, application areas, and market growth strategies.

  Sleep Apnea Implants Market Report Highlights

Aspects	Details
Market Size By 2031	USD 1.3 billion
Growth Rate	CAGR of 15.4%
Forecast period	2021 - 2031
Report Pages	211
By Product Type	Hypoglossal Neurostimulation Devices Phrenic Nerve Stimulator Others
By Indication	Obstructive Sleep Apnea Central Sleep Apnea
By End User	Hospitals Ambulatory Surgical Centers Others
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	Medtronic plc, SomnoMed, LinguaFlex, Inc, ASAHI KASEI CORP, Avery biomedical, Siesta Medical, Inspire Medical Systems, Inc., Somnowell, LivaNova PLC, Nyxoah SA

Analyst Review

The sleep apnea implant devices are widely used in people with sleep disorders in developed countries. The demand for sleep apnea implants can be seen to be increased due to rise in the prevalence of sleep disorder like sleep apnea.  

Moreover, the smokers are three times more likely to have obstructive sleep apnea than people who've never smoked. The smoking can increase the amount of inflammation and fluid retention in the upper airway. The growth in the demand from hospitals and other healthcare facilities for the implant devices are gaining significant rise seen in the developed countries owing to the benefits offered by the devices. 

Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of sleep apnea, increase in awareness about sleep apnea implant devices among the patient and increase in government expenditure on healthcare and other related trends adopted by the market players. 

Author Name(s) : Prathmesh Santosh Bhasme | Roshan Deshmukh

Related Tags

• Sleep Apnea
• Implantable Devices
• Respiratory Devices

^*Terms and Conditions Apply